Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant - PA: Patient-Oriented Research: Early-Career Investigator

McGill University

$100,000.00

Xi-Care: eXplainable intelligent system for Cardiovascular disease management among women in primary Care

FY 2019-20

Summary
Cardiovascular disease (CVD) remain the leading cause of death in Canadian women, and recent data suggest mortality is increasing. In Canada, 206 people (60% of them women) die of CVD every day. It cost Canada $20.9 billion per year. Most of these CVD can be prevented/managed. Identification of high-risk patients is not well done in particular in women, and prevention options are not often timely provided to them. Artificial Intelligent (AI) can play an important role in supporting clinicians and patients, yet rarely used. We aim to develop and test an explainable intelligent system, Xi-Care, which will help clinicians to accurately and timely predict risk of CVD (at point of care) and equip women with a system that gives personalized recommendations for lowering their risk of CVD. First, we will assess users (i.e. clinicians and women) needs and preferences regarding different aspects of CVD prediction and prevention in primary care. Then, along with users, we will develop an explainable AI solution that can predict the likelihood of having CVD in the future years based on different features among women, and recommend personalized preventive strategies to them-facilitating making informed value based decisions. Lastly, we will pilot test Xi-Care among clinicians and women, and improve it iteratively. Xi-Care is expected to improve CVD risk stratification and increase prediction accuracy and give personalized recommendations for CVD prevention. It will not only have high accuracy but will also allow users to understand why the system predicted risk/recommended a particular strategy. Xi-Care will be delivered in primary care-where women make their first and most frequent contact with the health care system-thus, it can play an important role in early detection of CVD and timely treatment. Xi-Care will be a first step toward saving millions of lives by advancing traditional female CVD prediction and prevention using explainable AI technologies.
Program
Project Grant - PA: Patient-Oriented Research: Early-Career Investigator
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
414281
Name
Abbasgholizadeh Rahimi Samira
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Health Services Evaluation & Interventions Research 3
Projecttitle
Xi-Care: eXplainable intelligent system for Cardiovascular disease management among women in primary Care
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - PA: Patient-Oriented Research: Early-Career Investigator
Keyworddelim
Cardiovascular Disease; Disease Prevention And Management; Explainable Artificial Intelligence; Machine Learning; Patient Engagement; Patient-Centered Care; Primary Health Care; Women
Abstract
Cardiovascular disease (CVD) remain the leading cause of death in Canadian women, and recent data suggest mortality is increasing. In Canada, 206 people (60% of them women) die of CVD every day. It cost Canada $20.9 billion per year. Most of these CVD can be prevented/managed. Identification of high-risk patients is not well done in particular in women, and prevention options are not often timely provided to them. Artificial Intelligent (AI) can play an important role in supporting clinicians and patients, yet rarely used. We aim to develop and test an explainable intelligent system, Xi-Care, which will help clinicians to accurately and timely predict risk of CVD (at point of care) and equip women with a system that gives personalized recommendations for lowering their risk of CVD. First, we will assess users (i.e. clinicians and women) needs and preferences regarding different aspects of CVD prediction and prevention in primary care. Then, along with users, we will develop an explainable AI solution that can predict the likelihood of having CVD in the future years based on different features among women, and recommend personalized preventive strategies to them-facilitating making informed value based decisions. Lastly, we will pilot test Xi-Care among clinicians and women, and improve it iteratively. Xi-Care is expected to improve CVD risk stratification and increase prediction accuracy and give personalized recommendations for CVD prevention. It will not only have high accuracy but will also allow users to understand why the system predicted risk/recommended a particular strategy. Xi-Care will be delivered in primary care-where women make their first and most frequent contact with the health care system-thus, it can play an important role in early detection of CVD and timely treatment. Xi-Care will be a first step toward saving millions of lives by advancing traditional female CVD prediction and prevention using explainable AI technologies.
Competitiondate
201909
Approvedterm2
1 yr 0 mth
Pinamesdelim
Abbasgholizadeh Rahimi, Samira
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~